UCB Australia
Presence
UCB is one of the...
UCB is a company listed under the stock ticker UCB (BE).
UCB has a direct presence in 10 countries.UCB has 10 subsidiaries including UCB Australia, UCB Canada and UCB France.
They are in:
- Pharmaceuticals91%
- Fund9%
Executives
View the org chart displaying its 3 main executives
Most searched biographies at UCB Australia
- Ian Worby, Managing Director
- Selina Clifford, Head of Neurology and Country Lead
- Francesca Bianco, Associate Director, Immunuology Business Unit
Create your alert
to follow the executive moves at UCB Australia.
Pharmaceuticals
UCB has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by UCB Australia
Social media about UCB Australia
- UCB Australia on Wikipedia, Google News & Yahoo Finance
- UCB Australia on LinkedIn, Twitter & YouTube
